Member access

4-Traders Homepage  >  Shares  >  SHANGHAI STOCK EXCHANGE  >  Jiangzhong Pharmaceutical Co Ltd    600750   CNE000000M80

End-of-day quote. End-of-day quote SHANGHAI STOCK EXCHANGE - 02/26
29.45 CNY   -0.77%
 SummaryQuotesChartsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
02/13/2015 02/16/2015 02/17/2015 02/25/2015 02/26/2015 Date
26.64(c) 27.13(c) 26.98(c) 29.68(c) 29.45 Last
4 932 790 4 015 095 2 812 757 13 691 851 6 635 980 Volume
-0.11% +1.84% -0.55% +10.01% -0.77% Change
More quotes
Company
Jiangzhong Pharmaceutical Co. Ltd. is engaged in the manufacture and sale of pharmaceutical products.Main products consist of Chinese, water-soluble and botanical medicines; penicillin injection and raw materials; capsules; antibiotics and others.Other activities include wholesale and retail of... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Surperformance© ratings of Jiangzhong Pharmaceutical
Trading Rating : Investor Rating :
More Ratings
Chart JIANGZHONG PHARMACEUTICAL
Duration : Period :
Jiangzhong Pharmaceutical  Technical Analysis Chart | 600750 | CNE000000M80 | 4-Traders
Full-screen chart
Financials ( CNY)
Sales 2014 3 492 M
EBIT 2014 253 M
Net income 2014 211 M
Finance 2014 424 M
Yield 2014 1,15%
Sales 2015 3 532 M
EBIT 2015 319 M
Net income 2015 276 M
Finance 2015 500 M
Yield 2015 1,33%
PER 2014 41,57
PER 2015 32,88
EV / Sales 2014 2,43x
EV / Sales 2015 2,38x
Capitalization 8 904 M
More Financials
Latest news on JIANGZHONG PHARMACEUTICAL

- No features available -

More news
Sector news Pharmaceuticals - NEC
05:20p JOHNSON & JOHNSON : Idaho House panel endorses banning contact lens price floors
04:58p ABBVIE : Ongoing Research in Neuroscience and Oncology will be Featured at the 2..
04:01p OTSUKA : First-Ever Treatment Approved in Canada for Adults Living with ADPKD, a..
Plus d'actualités du secteur Pharmaceuticals - NEC


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF